Cargando…

Cause of death during upper tract urothelial carcinoma survivorship: A contemporary, population-based analysis

BACKGROUND: Very few studies have been published on the causes of death of upper tract urothelial carcinoma (UTUC). We sought to explore the mortality patterns of contemporary UTUC survivors. METHODS: We performed a retrospective cohort study involving patients with upper urinary tract carcinoma fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Fu-Sheng, Wu, Wan-Ting, Zhang, Lu, Shen, Jia-Hua, Yu, Dong-Dong, Mao, Li-Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650258/
https://www.ncbi.nlm.nih.gov/pubmed/36387214
http://dx.doi.org/10.3389/fonc.2022.948289
_version_ 1784827973153587200
author Peng, Fu-Sheng
Wu, Wan-Ting
Zhang, Lu
Shen, Jia-Hua
Yu, Dong-Dong
Mao, Li-Qi
author_facet Peng, Fu-Sheng
Wu, Wan-Ting
Zhang, Lu
Shen, Jia-Hua
Yu, Dong-Dong
Mao, Li-Qi
author_sort Peng, Fu-Sheng
collection PubMed
description BACKGROUND: Very few studies have been published on the causes of death of upper tract urothelial carcinoma (UTUC). We sought to explore the mortality patterns of contemporary UTUC survivors. METHODS: We performed a retrospective cohort study involving patients with upper urinary tract carcinoma from the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) database (2000 and 2015). We used standardized mortality ratios (SMRs) to compare death rates among patients with UTUC in the general population and excess absolute risks (EARs) to quantify the disease-specific death burden. RESULTS: A total of 10,179 patients with UTUC, including 7,133 who died, were included in our study. In total, 302 (17.17%) patients with the localized disease died of UTUC; however, patients who died from other causes were 4.8 times more likely to die from UTUC (n = 1,457 [82.83%]). Cardiovascular disease was the most common non-cancer cause of death (n = 393 [22.34% of all deaths]); SMR, 1.22; 95% confidence intervals [CI], 1.1–1.35; EAR, 35.96). A total of 4,046 (69.99%) patients with regional stage died within their follow-up, 1,413 (34.92%) of whom died from UTUC and 1,082 (26.74%) of whom died from non-cancer causes. UTUC was the main cause of death (SMR, 242.48; 95% CI, 230–255.47; EAR, 542.47), followed by non-tumor causes (SMR, 1.18; 95% CI, 1.11–1.25; EAR, 63.74). Most patients (94.94%) with distant stage died within 3 years of initial diagnosis. Although UTUC was the leading cause of death (n = 721 [54.29%]), these patients also had a higher risk of death from non-cancer than the general population (SMR, 2.08; 95% CI, 1.67–2.56; EAR, 288.26). CONCLUSIONS: Non-UTUC deaths accounted for 82.48% of UTUC survivors among those with localized disease. Patients with regional/distant stages were most likely to die of UTUC; however, there is an increased risk of dying from non-cancer causes that cannot be ignored. These data provide the latest and most comprehensive assessment of the causes of death in patients with UTUC.
format Online
Article
Text
id pubmed-9650258
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96502582022-11-15 Cause of death during upper tract urothelial carcinoma survivorship: A contemporary, population-based analysis Peng, Fu-Sheng Wu, Wan-Ting Zhang, Lu Shen, Jia-Hua Yu, Dong-Dong Mao, Li-Qi Front Oncol Oncology BACKGROUND: Very few studies have been published on the causes of death of upper tract urothelial carcinoma (UTUC). We sought to explore the mortality patterns of contemporary UTUC survivors. METHODS: We performed a retrospective cohort study involving patients with upper urinary tract carcinoma from the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) database (2000 and 2015). We used standardized mortality ratios (SMRs) to compare death rates among patients with UTUC in the general population and excess absolute risks (EARs) to quantify the disease-specific death burden. RESULTS: A total of 10,179 patients with UTUC, including 7,133 who died, were included in our study. In total, 302 (17.17%) patients with the localized disease died of UTUC; however, patients who died from other causes were 4.8 times more likely to die from UTUC (n = 1,457 [82.83%]). Cardiovascular disease was the most common non-cancer cause of death (n = 393 [22.34% of all deaths]); SMR, 1.22; 95% confidence intervals [CI], 1.1–1.35; EAR, 35.96). A total of 4,046 (69.99%) patients with regional stage died within their follow-up, 1,413 (34.92%) of whom died from UTUC and 1,082 (26.74%) of whom died from non-cancer causes. UTUC was the main cause of death (SMR, 242.48; 95% CI, 230–255.47; EAR, 542.47), followed by non-tumor causes (SMR, 1.18; 95% CI, 1.11–1.25; EAR, 63.74). Most patients (94.94%) with distant stage died within 3 years of initial diagnosis. Although UTUC was the leading cause of death (n = 721 [54.29%]), these patients also had a higher risk of death from non-cancer than the general population (SMR, 2.08; 95% CI, 1.67–2.56; EAR, 288.26). CONCLUSIONS: Non-UTUC deaths accounted for 82.48% of UTUC survivors among those with localized disease. Patients with regional/distant stages were most likely to die of UTUC; however, there is an increased risk of dying from non-cancer causes that cannot be ignored. These data provide the latest and most comprehensive assessment of the causes of death in patients with UTUC. Frontiers Media S.A. 2022-10-28 /pmc/articles/PMC9650258/ /pubmed/36387214 http://dx.doi.org/10.3389/fonc.2022.948289 Text en Copyright © 2022 Peng, Wu, Zhang, Shen, Yu and Mao https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Peng, Fu-Sheng
Wu, Wan-Ting
Zhang, Lu
Shen, Jia-Hua
Yu, Dong-Dong
Mao, Li-Qi
Cause of death during upper tract urothelial carcinoma survivorship: A contemporary, population-based analysis
title Cause of death during upper tract urothelial carcinoma survivorship: A contemporary, population-based analysis
title_full Cause of death during upper tract urothelial carcinoma survivorship: A contemporary, population-based analysis
title_fullStr Cause of death during upper tract urothelial carcinoma survivorship: A contemporary, population-based analysis
title_full_unstemmed Cause of death during upper tract urothelial carcinoma survivorship: A contemporary, population-based analysis
title_short Cause of death during upper tract urothelial carcinoma survivorship: A contemporary, population-based analysis
title_sort cause of death during upper tract urothelial carcinoma survivorship: a contemporary, population-based analysis
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650258/
https://www.ncbi.nlm.nih.gov/pubmed/36387214
http://dx.doi.org/10.3389/fonc.2022.948289
work_keys_str_mv AT pengfusheng causeofdeathduringuppertracturothelialcarcinomasurvivorshipacontemporarypopulationbasedanalysis
AT wuwanting causeofdeathduringuppertracturothelialcarcinomasurvivorshipacontemporarypopulationbasedanalysis
AT zhanglu causeofdeathduringuppertracturothelialcarcinomasurvivorshipacontemporarypopulationbasedanalysis
AT shenjiahua causeofdeathduringuppertracturothelialcarcinomasurvivorshipacontemporarypopulationbasedanalysis
AT yudongdong causeofdeathduringuppertracturothelialcarcinomasurvivorshipacontemporarypopulationbasedanalysis
AT maoliqi causeofdeathduringuppertracturothelialcarcinomasurvivorshipacontemporarypopulationbasedanalysis